Jaime Gallego Perez-Larraya

10PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCharacterisation of biological macromoleculesInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 26, 2026
Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center Series.

Inés Esparragosa Vázquez, Ascensión López-Díaz de Cerio, Susana Inoges

|Nov 26, 2025
Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4.

Paula Rodríguez-Otero, Surbhi Sidana, Mathilde Kouwenhoven

|Mar 13, 2024
Dendritic Cells in Cancer Immunology and Immunotherapy.

Laura Hato, Angel Vizcay, Iñaki Eguren

|Feb 25, 2022
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies.

Adam D Cohen, Samir Parekh, Bianca D Santomasso

|Feb 14, 2022
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort.

Emilie Le Rhun, Patrick Devos, Sebastian Winklhofer

|Dec 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET.

Marc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano

Pageof 2

Frequent Collaborators

4 joint publications

Marta Zalacain

2 joint publications

Jose L Perez-Gracia

2 joint publications

Erin Lee

2 joint publications

Kevin C De Braganca